BIG PMEA NEWS! Been pounding the table for a while & it's

New Post Public Reply Private Reply Replies (0) Message Board
jay_tiger
247
BIG PMEA NEWS! Been pounding the table for a while & it's time to get in guys!

PM&E, Inc. To Expedite The Completion Of Audited Financials

Wyoming / Sousse, January 25, 2017 - InvestorsHub Newswire Aircraft manufacturer PM&E, Inc. (OTC: PMEA) announced today that the company has stepped up the pace of completion of audited financials for a very specific reason.

CEO Joseph Bourne stated, "One of our intermediate term goals is to up-list to the OTCQB level. One of the requirements to up-list is to trade above a penny for thirty days. Another is the requirement to be fully reporting. We feel strongly that these two objectives are mutually compatible. With that in mind, we have begun an aggressive search for the right partner for expediting the completion of audited financials. We are currently in discussions with several companies and feel that a decision should be made in the coming weeks.”

Mr. Bourne also stated, “Last week we announced that we are retiring over two thirds of all outstanding shares. To date we have pre-sold 33 EVADA Aircraft through exclusive and non-exclusive agency agreements. We have completed our partnership and shared revenue agreement with ultra-light gyrocopter manufacturer, DiNelly EXOGYRO. We are expanding our workforce above and beyond our already existing team of 35 full time employees. Late last week we secured a 10 million dollar funding package. The step of expediting audited financials is just the latest component of our growth and expansion plans and one that will help to ensure integrity throughout the process.”

Mr. Bourne finished up with, “Some have had questions about the trading trends of our stock as of late and the true value of the company. Here is my response and for the most part, it comes down to exposure, financials and access. 1) We were originally putting out press releases via a service that did not have universal syndication. We have remedied that and all major press releases from this point forward will be sent out via a major news wire. 2) I will be sitting down soon for a Q&A session about our company and I will publish the transcript of that discussion on our corporate website so that all investors can gain further insight into our overall business strategy. 3) The expediting of audited financials will hopefully allow us to publish the results earlier than originally planned. 4) We have a DTC Chill that came with the ticker symbol itself.” We thought that it would have been lifted by now, but just know that we are working daily to get that removed so that all interested investors may purchase our stock through all available channels.”

He continued: “As far as the value of the company is concerned, I cannot comment on the current price per share other than to say that we feel strongly that our conservative target of 25 million in revenue and 7 million in EBITDA will be met this year. Now that we are retiring shares and reducing our outstanding share count to 5.115 billion shares with 1.575 billion shares in the float, we’ll leave it up to the investment community and the markets to determine the value of our stock. We are confident that the company’s true market value will be reflected soon enough. As always, we would like to thank our existing shareholders for their support to date.”

PM&E, Inc. is an aircraft company with a contracted manufacturing facility located in Sousse, Tunisia. The company is in the process of implementing a modern manufacturing plant in Tunisia and securing a facility for aircraft assembly in Wyoming. The company manufactures their signature line of EVADA Aircraft. Through a strategic partnership, DiNelly EXOGYRO also manufactures their commercial ultra-light gyrocopters at the same facility in Tunisia creating synergies and cost savings for both companies through a shared resources and revenues agreement.

http://www.pme-holding.com
http://www.dinelly-exogyro.com

Facebook : https://www.facebook.com/PME-Inc-432293210274534/
Google + : https://plus.google.com/u/0/110058910223174354829?hl=fr
Twitter : https://twitter.com/PMEA_Inc
Youtube : https://www.youtube.com/channel/UCUUREk7BtuTwfWVQEgBDqnA
Linkedin : https://www.linkedin.com/company/1
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 35

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 26

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 23

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 32

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Kotak Mahindra Bank's Innovative Tech Strategies

Updated Category News Views 587

Kotak Mahindra Bank's Commitment to Digital Transformation Kotak Mahindra Bank is at the forefront of revolutionizing financial services through its innovative technology strategies. Their latest report dives deep into the bank's extensive tech activities, highlighting how it leverages digital transformation to enhance customer experience and streamline operations....

Continue Reading
Star Group, L.P. Reflects on Fiscal 2024 Performance Updates

Updated Category News Views 349

Star Group's Fiscal 2024 Insights and Performance Analysis As the fiscal year wraps up, Star Group, L.P. (NYSE: SGU), a respected home energy distributor, shares its financial performance that ended on September 30, 2024. Amidst the prevailing challenges in the energy market, the company continues its commitment to delivering quality services while adapting to market...

Continue Reading
Krystal Biotech Launches Clinical Trial for Eye Therapy KB801

Updated Category News Views 148

Krystal Biotech Begins Phase 1/2 Trial of KB801 Krystal Biotech, Inc. (NASDAQ: KRYS) has recently announced exciting developments in its ophthalmology pipeline with the initiation of a Phase 1/2 clinical trial for KB801, aimed at treating neurotrophic keratitis (NK). This 2:1 randomized, double-masked, multicenter, placebo-controlled study, named EMERALD-1, marks a...

Continue Reading
Key Updates on the Annual General Meeting of Ignitis Group

Updated Category News Views 163

Exciting Updates for the Ignitis Group Shareholders The retained earnings figure for AB “Ignitis grup?” has been amended for the upcoming Annual General Meeting. It now stands at EUR 320,319,368.41, following a revision made only to the English version of the document. This adjustment reflects the company’s commitment to transparency and accuracy in their financial...

Continue Reading
Transforming Connectivity: The Future of mmWave Sensors Growth

Updated Category News Views 104

The mmWave sensors market was set on a blistering growth path back in 2023, valued at around USD 0.25 billion. By the time you fast-forward to 2032, projections had it skyrocketing to USD 2.40 billion, boasting a staggering CAGR of 28.59% from 2024 through 2032. You'd think this kind of momentum would have traders buzzing—oh wait, they were, especially as the push for...

Continue Reading